Brief: Immunovia Will Launch Next-Generation Test In 2025 H2

Immunovia AB (publ)

27/11/2024 07:55

Nov 27 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * LOOKING AHEAD TO 2025, WE WILL TRANSITION FROM FOCUSING ON
RESEARCH AND DEVELOPMENT TO COMMERCIALIZING NEW TEST
    * WE WILL EXECUTE A TARGETED LAUNCH OF NEXT-GENERATION TEST
IN
SECOND HALF OF 2025
    * WE EXPECT TO CONDUCT A TARGETED LAUNCH OF NEXT-GENERATION
TEST
IN UNITED STATES IN SECOND HALF OF 2025
    * WE EXPECT REIMBURSEMENT OF TEST TO COME IN 2026 AFTER
PAYER
REVIEW OF PUBLISHED CLINICAL STUDY RESULTS.
    * WE WILL CONDUCT TWO ADDITIONAL CLINICAL VALIDITY STUDIES
IN
HIGH-RISK HEREDITARY PATIENT POPULATION IN FIRST HALF OF 2025

Source text:  ID:nWkrc44yTS 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))